LianBio Quarterly Operating Income (Loss) in USD from Q3 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
LianBio quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2023.
  • LianBio Operating Income (Loss) for the quarter ending September 30, 2023 was -$26.3M, a 7.14% decline year-over-year.
  • LianBio Operating Income (Loss) for the twelve months ending September 30, 2023 was -$107M, a 9.81% increase year-over-year.
  • LianBio annual Operating Income (Loss) for 2022 was -$125M, a 35.9% increase from 2021.
  • LianBio annual Operating Income (Loss) for 2021 was -$196M, a 45% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$107M -$26.3M -$1.75M -7.14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$105M -$25M +$18.1M +42% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$123M -$26M +$2.45M +8.62% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$125M -$29.2M -$7.21M -32.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$118M -$24.5M -$11M -81.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$107M -$43.1M +$56.3M +56.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$163M -$28.4M +$32.1M +53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$196M -$22M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$13.5M +$106M +88.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$99.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$60.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$119M Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-01-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.